combining glp-1 receptor agonist with dpp-4 inhibitor not recommended guideline Clinical Use of Inhibitors Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
If you or a loved one suffered injuries, property damage, or other financial losses due to another partys actions, you may be entitled to compensation for those losses
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic poly-peptide (GIP, previously known as gastric inhibitory polypeptide) are key incretin hormones secreted from the small intestine after oral intake of food
Madsen K, Knudsen LB, Agersoe H, et al
doi: 10.1016/j.ejphar.2011.11.005 150 ZhouMChenSPengPGuZYuJZhaoGet al
